We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$76.2B
AUM Growth
+$3.6B
Cap. Flow
-$379M
Cap. Flow %
-0.5%
Top 10 Hldgs %
46.27%
Holding
781
New
70
Increased
299
Reduced
299
Closed
89

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$510M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$297M
3
BLDR icon
Builders FirstSource
BLDR
+$110M
4
AMZN icon
Amazon
AMZN
+$91.9M
5
LSGR icon
Natixis Loomis Sayles Focused Growth ETF
LSGR
+$77.1M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$114M
2
META icon
Meta Platforms (Facebook)
META
+$87.2M
3
NFLX icon
Netflix
NFLX
+$77.3M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$65.6M
5
ACN icon
Accenture
ACN
+$58.8M

Sector Composition

Rank Sector Weight
1 Technology 27.59%
2 Consumer Discretionary 17.53%
3 Communication Services 17.38%
4 Healthcare 13.08%
5 Financials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WRBY icon
201
Warby Parker
WRBY
$3.27B
$29.1M 0.04%
1,782,629
+300,891
+20% +$4.53M
TBBK icon
202
The Bancorp
TBBK
$2.84B
$28.6M 0.04%
535,366
-12,770
-2% -$617K
AX icon
203
Axos Financial
AX
$5.68B
$28.5M 0.04%
453,425
+39,091
+9% +$2.57M
VVV icon
204
Valvoline
VVV
$4.51B
$28.2M 0.04%
673,115
-1,156
-0.2% -$49.1K
RXO icon
205
RXO
RXO
$3.58B
$28M 0.04%
+998,709
New +$28.2M
XENE icon
206
Xenon Pharmaceuticals
XENE
$6.12B
$27.8M 0.04%
707,222
+46,964
+7% +$1.89M
ASND icon
207
Ascendis Pharma A/S
ASND
$16.8B
$27.6M 0.04%
184,623
+63,029
+52% +$8.51M
CIEN icon
208
Ciena
CIEN
$58.4B
$27.3M 0.04%
443,927
-10,225
-2% -$539K
AGIO icon
209
Agios Pharmaceuticals
AGIO
$1.93B
$27.2M 0.04%
612,366
+163,503
+36% +$7.43M
BIDU icon
210
Baidu
BIDU
$37.2B
$27.1M 0.04%
257,581
-8,442
-3% -$746K
NOMD icon
211
Nomad Foods
NOMD
$1.68B
$27M 0.04%
1,418,497
+289,090
+26% +$5.32M
NVMI
212
Nova
NVMI
$12.5B
$26.9M 0.04%
129,268
-36,945
-22% -$7.88M
AXSM icon
213
Axsome Therapeutics
AXSM
$10.9B
$26.8M 0.04%
298,586
+29,497
+11% +$2.57M
HRI icon
214
Herc Holdings
HRI
$5.61B
$26.6M 0.03%
166,915
-2,511
-1% -$356K
LFUS icon
215
Littelfuse
LFUS
$11.6B
$26.3M 0.03%
99,136
-1,542
-2% -$397K
PCOR icon
216
Procore
PCOR
$8.67B
$26.1M 0.03%
423,114
-9,769
-2% -$600K
THRM icon
217
Gentherm
THRM
$1.27B
$26.1M 0.03%
560,593
-12,907
-2% -$641K
GNTX icon
218
Gentex
GNTX
$5.07B
$25.8M 0.03%
867,731
-1,493
-0.2% -$46.4K
NOG icon
219
Northern Oil and Gas
NOG
$2.35B
$25.7M 0.03%
726,581
-147,869
-17% -$5.64M
CSW
220
CSW Industrials
CSW
$5.71B
$25.6M 0.03%
+69,842
New +$21.8M
POST icon
221
Post Holdings
POST
$3.57B
$25.4M 0.03%
219,585
-3,292
-1% -$369K
CMPR icon
222
Cimpress
CMPR
$2.31B
$25.3M 0.03%
309,032
-39,650
-11% -$3.52M
VECO icon
223
Veeco
VECO
$3.23B
$24.9M 0.03%
751,003
+216,616
+41% +$8.12M
ADC icon
224
Agree Realty
ADC
$9.41B
$24M 0.03%
318,831
-4,283
-1% -$303K
EXP icon
225
Eagle Materials
EXP
$6.57B
$23.6M 0.03%
81,969
+279
+0.3% +$69.8K
7 8
9
10 11

Similar funds

CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Loomis, Sayles & Company's Q3 2024 Portfolio in Review

As of Q3 2024, Loomis, Sayles & Company held 781 positions worth $76.2B, up 5% from $72.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Loomis, Sayles & Company's Q3 2024 filing shows 70 new, 299 increased, 299 reduced and 89 closed positions. Its largest new stake was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M. The largest sale was Oracle, an estimated $114M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q3 2024 buy was Rhythm Pharmaceuticals: 636,628 shares worth $33.4M.
  • Loomis, Sayles & Company added most to Nike in Q3 2024, an estimated $510M increase.
  • Loomis, Sayles & Company's biggest Q3 2024 reduction was Oracle, cutting an estimated $114M.
  • Loomis, Sayles & Company fully exited Simply Good Foods in Q3 2024, selling an estimated $58.7M.
  • Loomis, Sayles & Company's ten largest holdings make up 46% of its $76.2B portfolio in Q3 2024.
  • Loomis, Sayles & Company opened 70 new positions and closed 89 in Q3 2024.
  • Loomis, Sayles & Company's portfolio value rose 5% quarter-over-quarter to $76.2B.

Based on Loomis, Sayles & Company's 13F filing for Q3 2024, filed 13 Nov 2024.